Eli Lilly’s CEO has warned against the hoarding of medicines by individual states and countries in the coronavirus crisis, saying that it will hamper the effort to fight the virus.
Canadian biotech AbCellera has joined forces with Eli Lilly to co-develop antibody products to prevent and treat COVID-19, the disease caused by the novel SARS-Cov-2 coronavirus.
The coronavirus has begun to affect day-to-day operations at pharma companies, with Biogen dealing with an outbreak linked to a management meeting at an affected hotel, and others telling s